Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 631

1.

A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression.

Rudolph RL, Feiger AD.

J Affect Disord. 1999 Dec;56(2-3):171-81.

PMID:
10701474
[PubMed - indexed for MEDLINE]
2.

Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group.

Silverstone PH, Ravindran A.

J Clin Psychiatry. 1999 Jan;60(1):22-8.

PMID:
10074873
[PubMed - indexed for MEDLINE]
3.
4.
5.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
[PubMed - indexed for MEDLINE]
6.

Global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetine.

Entsuah R, Gorman JM.

J Psychiatr Res. 2002 May-Jun;36(3):111-8.

PMID:
11886688
[PubMed - indexed for MEDLINE]
7.

Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder.

Silverstone PH, Salinas E.

J Clin Psychiatry. 2001 Jul;62(7):523-9.

PMID:
11488362
[PubMed - indexed for MEDLINE]
8.

A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression.

Schatzberg A, Roose S.

Am J Geriatr Psychiatry. 2006 Apr;14(4):361-70.

PMID:
16582045
[PubMed - indexed for MEDLINE]
9.

Venlafaxine extended-release: a review of its use in the management of major depression.

Wellington K, Perry CM.

CNS Drugs. 2001;15(8):643-69. Review.

PMID:
11524036
[PubMed - indexed for MEDLINE]
10.

Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo.

Shelton C, Entsuah R, Padmanabhan SK, Vinall PE.

Int Clin Psychopharmacol. 2005 Jul;20(4):233-8.

PMID:
15933485
[PubMed - indexed for MEDLINE]
11.

The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.

Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen RD, Yan B, Ahmed S, Musgnung J, Ninan PT.

J Clin Psychiatry. 2007 Aug;68(8):1246-56.

PMID:
17854250
[PubMed - indexed for MEDLINE]
12.

Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.

Davidson JR, DuPont RL, Hedges D, Haskins JT.

J Clin Psychiatry. 1999 Aug;60(8):528-35.

PMID:
10485635
[PubMed - indexed for MEDLINE]
13.

A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.

Bielski RJ, Ventura D, Chang CC.

J Clin Psychiatry. 2004 Sep;65(9):1190-6.

PMID:
15367045
[PubMed - indexed for MEDLINE]
14.

Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.

Hewett K, Chrzanowski W, Schmitz M, Savela A, Milanova V, Gee M, Krishen A, Millen L, Leary MO, Modell J.

J Psychopharmacol. 2009 Jul;23(5):531-8. doi: 10.1177/0269881108089602. Epub 2008 Jul 17.

PMID:
18635695
[PubMed - indexed for MEDLINE]
15.

A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression.

Rudolph RL, Fabre LF, Feighner JP, Rickels K, Entsuah R, Derivan AT.

J Clin Psychiatry. 1998 Mar;59(3):116-22.

PMID:
9541154
[PubMed - indexed for MEDLINE]
16.

Remission rates with venlafaxine extended release in Greek outpatients with generalized anxiety disorder. A double-blind, randomized, placebo controlled study.

Nimatoudis I, Zissis NP, Kogeorgos J, Theodoropoulou S, Vidalis A, Kaprinis G.

Int Clin Psychopharmacol. 2004 Nov;19(6):331-6.

PMID:
15486518
[PubMed - indexed for MEDLINE]
17.

Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatients.

Feighner JP, Entsuah AR, McPherson MK.

J Affect Disord. 1998 Jan;47(1-3):55-62.

PMID:
9476744
[PubMed - indexed for MEDLINE]
18.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
[PubMed - indexed for MEDLINE]
19.

Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression.

Costa e Silva J.

J Clin Psychiatry. 1998 Jul;59(7):352-7.

PMID:
9714263
[PubMed - indexed for MEDLINE]
20.

Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.

Davidson JR, Meoni P, Haudiquet V, Cantillon M, Hackett D.

Depress Anxiety. 2002;16(1):4-13.

PMID:
12203668
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk